Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | ADRA2C | P18825 | 5/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 4/20 | 0.46 |
| ▸ | ADRA2B | P18089 | 4/20 | 0.46 |
| ▸ | HTR1A | P08908 | 4/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.46 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.44 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | HTR2B | P41595 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8961940 | 1.00 | ALDH1A1 (0.47) | ALDH1A1ADRA2CADRA2AADRA2BHTR1A | |
| SCHEMBL8961842 | 0.89 | ALDH1A1 (0.47) | ALDH1A1ADRA2CADRA2AADRA2BHTR1A | |
| SCHEMBL8961862 | 0.86 | ALDH1A1 (0.48) | ALDH1A1ADRA2CADRA2AADRA2BHTR1A | |
| SCHEMBL8961880 | 0.83 | ALDH1A1 (0.43) | ALDH1A1ADRA2CADRA2AADRA2BHTR1A | |
| SCHEMBL1931040 | 0.83 | ALDH1A1 (0.43) | ALDH1A1ADRA2CADRA2AADRA2BHTR1A | |
| SCHEMBL8961909 | 0.82 | MAPT (0.45) | ALDH1A1ADRA2CADRA2AADRA2BHTR1A | |
| SCHEMBL8962288 | 0.81 | ADRA2C (0.46) | ALDH1A1ADRA2CADRA2AADRA2BHTR1A | |
| SCHEMBL9843615 | 0.81 | ADRA2C (0.52) | ALDH1A1ADRA2CADRA2AADRA2BHTR1A | |
| SCHEMBL8961911 | 0.80 | ALDH1A1 (0.44) | ALDH1A1ADRA2CADRA2AADRA2BHTR1A | |
| SCHEMBL8961780 | 0.80 | ALDH1A1 (0.43) | ALDH1A1ADRA2CADRA2AADRA2BHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260081229-A1 | ELECTROLYTIC SOLUTION AND BATTERY | GUANGZHOU TINCI MATERIALS TECH CO LTD (CN) | 2026-03-19 | — | — | US | claimed |
| EP-4708442-A1 | ELECTROLYTE AND BATTERY | Guangzhou Tinci Materials Technology Co., Ltd. (CN) | 2026-03-11 | — | — | EP | claimed |
| US-20250266502-A1 | LITHIUM-ION BATTERY ELECTROLYTIC SOLUTION, LITHIUM-ION BATTERY, AND METHOD FOR IMPROVING BATTERY PERFORMANCE | Guangzhou Tinci Materials Technology Co., Ltd (CN) | 2025-08-21 | — | — | US | claimed |
| CN-119786576-A | Positive electrode material, composite positive electrode material, positive electrode plate, preparation method and lithium ion power battery | 孝感楚能新能源创新科技有限公司 | 2025-04-08 | — | — | CN | claimed |
| WO-2022135873-A1 | COMPONENT, ELECTROCHEMICAL CELL AND METHOD FOR PRODUCING A COMPONENT | ELRINGKLINGER AG (DE) | 2022-06-30 | — | — | WO | claimed |
| US-20260081229-A1 | ELECTROLYTIC SOLUTION AND BATTERY | GUANGZHOU TINCI MATERIALS TECH CO LTD (CN) | 2026-03-19 | — | — | US | disclosed |
| EP-4708442-A1 | ELECTROLYTE AND BATTERY | Guangzhou Tinci Materials Technology Co., Ltd. (CN) | 2026-03-11 | — | — | EP | disclosed |
| US-20250266502-A1 | LITHIUM-ION BATTERY ELECTROLYTIC SOLUTION, LITHIUM-ION BATTERY, AND METHOD FOR IMPROVING BATTERY PERFORMANCE | Guangzhou Tinci Materials Technology Co., Ltd (CN) | 2025-08-21 | — | — | US | disclosed |
| CN-119786576-A | Positive electrode material, composite positive electrode material, positive electrode plate, preparation method and lithium ion power battery | 孝感楚能新能源创新科技有限公司 | 2025-04-08 | — | — | CN | disclosed |
| WO-2022135873-A1 | COMPONENT, ELECTROCHEMICAL CELL AND METHOD FOR PRODUCING A COMPONENT | ELRINGKLINGER AG (DE) | 2022-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260081229-A1 | ELECTROLYTIC SOLUTION AND BATTERY | NHERF1, CLIC4, SLC10A6 | ALDH1A1 3692/4885ADRA2C 4859/4885ADRA2A 4863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.